Epstein-Barr Virus antigens of therapeutic importance: Presentation via HLA class I & class II pathways

Project Details

Short titleEpstein-Barr Virus antigens of therapeutic importance: Presentation via HLA class I & class II pathways
StatusFinished
Effective start/end date3/01/002/06/03

Funding

  • Cancer Research UK